Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
REGISTERED CHARITY NUMBER: 800213
REPORT OF THE TRUSTEES AND
UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
FOR
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
Johnsons, Chartered Accountants 1-2 Craven Road
Ealing London W5 2UA
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
| Page | |||
|---|---|---|---|
| Report of the trustees | 1 | to | 4 |
| Independent examiner's report | 5 | ||
| Statement of financial activities | 6 | ||
| Balance sheet | 7 | ||
| Notes to the financial statements | 8 | to | 12 |
| Detailed statement of financial activities | 13 |
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024
The trustees present their report with the financial statements of the charity for the year ended 30 June 2024. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES Objectives and aims
Summary of the objects of the charity set out in its governing document
The British Society for Dermatological Surgery (BSDS) are the UK leaders in the field of Dermatological Surgery. The purpose of the Society is to promote, for the public benefit, interest in and knowledge of Dermatological Surgery.
The BSDS have a range of meetings and courses that run throughout the year and offer fellowships and awards. The BSDS provide resources, such as surgical log books, case studies and peer reviews for the benefit of medical professionals. They have also produced minimum standards documents and position statements on issues relating to Dermatological Surgery.
A scientific meeting relating to the objects of the Society shall be arranged at least once a year by the Executive Committee. One such meeting shall be held in association with the Annual General Meeting. Contributions to scientific meetings shall be regarded as private unless permission for publication is given specifically.
Aims & activities
Teaching and education of health care professionals. Education of patients. Research in skin cancer and skin surgery.
The Society maintains its aim of promoting skin cancer and skin surgery research and education through its clinical meetings, website and newsletter and with healthy competition for the travel fellowship as well as the undergraduate medical student essay prize.
In planning our activities for the year the trustees kept in mind the Charity Commission's guidance on public benefit.
Page 1
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024
ACHIEVEMENT AND PERFORMANCE
Summary of the main achievements of the charity during the year
Dermatological surgery continues to be an increasingly popular subspecialty with the BSDS membership continually growing. Currently there are over 400 members (426 in total), with 246 ordinary members and 93 trainee members.
The BSDS celebrated 40 years in 2023, facilitating over 4 courses each year; 2 clinical meetings; an executive committee of 16 members; a modernised functioning website and two Executive Officers.
In March 2024, the fifth and final BSDS/BAD Virtual Surgery educational modules were published chaired by Dr Vindy Ghura and Dr Dina Ismail. The modules cover the following topics - Pre-operative assessment and management of the medically complex patient, Surgical Anatomy, Local Anaesthetic, Biopsy techniques, Consent and Medicolegal matters.
The core focus of the BSDS continues to be education and training and the following events took place between July 2023 and June 2024:
Examples of Meetings and Events July 2023 - June 2024
Stitch-Up! A Suturing Course, held at Vesalius Training Centre, University of Bristol organised by Dr Emma Pynn, was attended by 76 delegates on 12.07.2023.
Advanced Meeting, held at Downing College, University of Cambridge: 2-day meeting dedicated to Mohs Micrographic Surgery. Featuring guest speakers from around the globe.The introductory lectures looked at the current state of Mohs surgery in the UK with respect to standards, quality and research. The histology section started with an introductory lecture on Mohs pearls and ended with a complex tumour board. Chaired by Dr Shiu Chan, Dr Niamh Flanagan and Dr Thomas Ha, was attended by 87 delegates on 20.09.2023.
Clinical Meeting, held virtually and chaired by Dr Lisa Naysmith: The Theme of this meeting was: 'What's at the cutting edge' attended by 138 delegates with guest speakers, Prof Colin Fleming, Mr Ben Aldridge, Dr David de Berker and Prof Catherine Harwood on 16.11.2023.
18th Annual Trainee Day, held virtually and organised by Dr Richard Barlow, BSDS Trainee representative and attended by 40 delegates on 23.11.2023.
Clinical Meeting, held virtually and chaired by Dr Dev Shah: The Theme of this meeting was: 'Future skin cancer management and a review of Mohs fellowships in UK' attended by 178 delegates with guest speakers Dr Katie Lacy, Dr Will Hunt, Dr Brogan Salence, Dr Roisin O'Connor, Dr Sunita Odedra, Mr Alastair Mackenzie-Ross, Mr Richard Scawn on 21.03.2024.
40th Annual Surgery Workshop, held at Newcastle Medical School, Newcastle Upon Tyne over three days. Chaired by Dr Richard Motley and Dr Rachel Abbott: This practical based surgical course was attended by 100 delegates and 32 teaching faculties on 15.04.2024.
Awards and Prizes
Medical Student Essay Prize
In July 2023, Zoe Hemsley studying at Cambridge University won £300 for their essay on 'How can we ensure valid consent in dermatologic surgery in the era of teledermatology and one-stop clinics'?'
In January 2024, Talia Patel, studying at the University of Nottingham Medical School, won £300 for their submission on 'Create a PIL on Mohs Micrographic surgery'.
Traveling Fellowship Award
In January 2024, Dr Beatriz Suarez Martinez-Falero was awarded £1,500 to help fund her attendance on the American College of Mohs Surgery (ACMS) Annual Meeting in Phoenix followed by an observatorship at the United Stated Dermatology Practice with Dr Nathalie Zeituni in May 2024.
Page 2
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024
Trustee remunerations and reimbursements
No trustees were remunerated for services provided for and on behalf of the charity.
FINANCIAL REVIEW
Financial position
Total receipts for the year were £236,119 the majority of which related to the annual surgery workshop/course registration fees. Total expenditure, including asset purchases, for the year amounted to £250,922 and the net result was a decrease in cash held of £14,803 year on year.
Reserves policy
The Society's reserves are maintained in order to cover the prospect of 3-4 years of loss of income, particularly with respect to staff costs and potential future pandemic causing hardship.
STRUCTURE, GOVERNANCE AND MANAGEMENT Governing document
The charity is controlled by its governing document, a deed of trust and constitutes an unincorporated charity.
Governing document
The governing document is the society's constitution dated 02 July 2024.
Constitution of Charity
The charity is a society.
Trustee Selection Methods
The President, President Elect, Secretary, Treasurer, Newsletter Editor and other ordinary members of the Committee shall be elected at the Annual General Meeting. Nominations may be made by the Committee or by any two members and shall be sent, together with the written consent of the Nominee, to the Secretary not less than two months before the Annual General Meeting. Such nominations shall be circulated with a notice of that Meeting. Members unable to attend shall be entitled to vote by post. If other nominations are not received for the filling of vacancies, the Committee's nominees shall be deemed elected.
Any vacancy occurring on the Committee other than by retirement may be filled by a member to be co-opted by the Committee.
The Committee may co-opt other members as it sees fit.
REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number
800213
Principal address
Willan House 4 Fitzroy Square London W1T 5HQ
Trustees
Dr H Ghura Dr Dr A Bray Dr T Oliphant Dr S Keohane Dr L Naysmith Dr W Hussain Dr A Wernham (appointed 1.7.2023)
Page 3
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024
REFERENCE AND ADMINISTRATIVE DETAILS Independent Examiner
Edmund Cartwright FCCA FMAAT Johnsons, Chartered Accountants 1-2 Craven Road Ealing London W5 2UA
Approved by order of the board of trustees on 11 March 2025 and signed on its behalf by:
Dr T Oliphant - Trustee
Page 4
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
Independent examiner's report to the trustees of British Society for Dermatological Surgery
I report to the charity trustees on my examination of the accounts of British Society for Dermatological Surgery (the Trust) for the year ended 30 June 2024.
Responsibilities and basis of report
As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Edmund Cartwright FCCA FMAAT
Johnsons, Chartered Accountants 1-2 Craven Road Ealing London W5 2UA
11 March 2025
Page 5
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 30 JUNE 2024
| 2024 Unrestricted fund as Notes £ INCOME AND ENDOWMENTS FROM Charitable activities CHARITABLE ACTIVITIES 232,091 Investment income 2 4,028 Total 236,119 EXPENDITURE ON Charitable activities CHARITABLE ACTIVITIES 250,922 NET INCOME/(EXPENDITURE) (14,803) RECONCILIATION OF FUNDS Total funds brought forward As previously reported 293,255 Prior year adjustment 5 (11,834) As restated 281,421 TOTAL FUNDS CARRIED FORWARD 266,618 |
2023 Total funds restated £ 286,562 5,618 292,180 303,223 (11,043) 292,464 - 292,464 281,421 |
|---|---|
The notes form part of these financial statements
Page 6
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
BALANCE SHEET 30 JUNE 2024
| 2024 | 2023 | ||
|---|---|---|---|
| Unrestricted | Total | ||
| fund | funds | ||
| as restated | |||
| Notes | £ | £ | |
| FIXED ASSETS | |||
| Tangible assets | 6 | 669 | 1,003 |
| Investments | 7 | 1,054 | 119,871 |
| 1,723 | 120,874 | ||
| CURRENT ASSETS | |||
| Debtors | 8 | 4,030 | 3,865 |
| Cash at bank | 283,156 | 166,822 | |
| 287,186 | 170,687 | ||
| CREDITORS | |||
| Amounts falling due within one year | 9 | (22,291) | (10,140) |
| NET CURRENT ASSETS | 264,895 | 160,547 | |
| TOTAL ASSETS LESS CURRENT | |||
| LIABILITIES | 266,618 | 281,421 | |
| NET ASSETS | 266,618 | 281,421 | |
| FUNDS | 10 | ||
| Unrestricted funds | 266,618 | 281,421 | |
| TOTAL FUNDS | 266,618 | 281,421 |
The financial statements were approved by the Board of Trustees and authorised for issue on 11 March 2025 and were signed on its behalf by:
T Oliphant - Trustee
The notes form part of these financial statements
Page 7
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33.33% on cost
Taxation
The charity is exempt from tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the Statement of financial activities on a straight line basis over the period of the lease.
Pension costs and other post-retirement benefits
The charity operates a defined contribution pension scheme. Contributions payable to the charity's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.
continued...
Page 8
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 JUNE 2024
2. INVESTMENT INCOME
| INVESTMENT INCOME | ||
|---|---|---|
| 2024 | 2023 | |
| as restated | ||
| £ | £ | |
| Deposit account interest | 4,028 | 5,618 |
3. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the year ended 30 June 2024 nor for the year ended 30 June 2023.
Trustees' expenses
There were no trustees' expenses paid for the year ended 30 June 2024 nor for the year ended 30 June 2023.
4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
| Unrestricted | |
|---|---|
| fund | |
| as restated | |
| £ | |
| INCOME AND ENDOWMENTS FROM | |
| Charitable activities | |
| CHARITABLE ACTIVITIES | 286,562 |
| Investment income | 5,618 |
| Total | 292,180 |
| EXPENDITURE ON | |
| Charitable activities | |
| CHARITABLE ACTIVITIES | 303,223 |
| NET INCOME/(EXPENDITURE) | (11,043) |
| RECONCILIATION OF FUNDS | |
| Total funds brought forward | 292,464 |
| TOTAL FUNDS CARRIED FORWARD | 281,421 |
continued...
Page 9
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 JUNE 2024
5. PRIOR YEAR ADJUSTMENT
The financial statements for the year ended 30 June 2023 have been restated due to a change from the receipt and payment basis to the accrual basis of accounting. Under the accrual basis, deferred income and debtors have been recognised, which were previously excluded.
6. TANGIBLE FIXED ASSETS
| Cost At 1 July 2023 and 30 June 2024 Depreciation At 1 July 2023 Charge for year At 30 June 2024 Net book value At 30 June 2024 At 30 June 2023 7. FIXED ASSET INVESTMENTS Other There were no investment assets outside the UK. Investments (neither listed nor unlisted) were as follows: M&G Investments 8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Trade debtors |
Computer equipment £ 1,337 334 334 668 669 1,003 2024 2023 as restated £ £ 1,054 119,871 2024 2023 as restated £ £ 1,054 119,871 2024 2023 as restated £ £ 4,030 3,865 |
|---|---|
continued...
Page 10
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 JUNE 2024
9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
| Trade creditors Taxation and social security Other creditors 10. MOVEMENT IN FUNDS Unrestricted funds General fund TOTAL FUNDS Net movement in funds, included in the above are as Unrestricted funds General fund TOTAL FUNDS Comparatives for movement in funds Unrestricted funds General fund TOTAL FUNDS |
Prior year At 1/7/23 adjustment £ £ 293,255 (11,834) 293,255 (11,834) follows: Incoming resources £ 236,119 236,119 At 1/7/22 £ 292,464 292,464 |
2024 2023 as restated £ £ - 785 1,586 - 20,705 9,355 22,291 10,140 Net movement At in funds 30/6/24 £ £ (14,803) 266,618 (14,803) 266,618 Resources Movement expended in funds £ £ (250,922) (14,803) (250,922) (14,803) Net movement At in funds 30/6/23 £ £ (11,043) 281,421 (11,043) 281,421 |
|---|---|---|
continued...
Page 11
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 30 JUNE 2024
10. MOVEMENT IN FUNDS - continued
Comparative net movement in funds, included in the above are as follows:
| Unrestricted funds General fund TOTAL FUNDS |
Incoming resources £ 292,180 292,180 |
Resources Movement expended in funds £ £ (303,223) (11,043) (303,223) (11,043) |
|---|---|---|
A current year 12 months and prior year 12 months combined position is as follows:
| Unrestricted funds General fund TOTAL FUNDS |
Prior year At 1/7/22 adjustment £ £ 292,464 (11,834) 292,464 (11,834) |
Net movement in funds £ (25,846) (25,846) |
At 30/6/24 £ 254,784 |
|---|---|---|---|
| 254,784 |
A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:
| Unrestricted funds General fund TOTAL FUNDS |
Incoming resources £ 528,299 528,299 |
Resources Movement expended in funds £ £ (554,145) (25,846) (554,145) (25,846) |
|---|---|---|
11. RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 30 June 2024.
Page 12
Docusign Envelope ID: FF701900-0A80-464C-9D25-805A23B39129Docusign Envelope ID: C91EB092-FF89-4348-9B3C-A6FD9939E960
BRITISH SOCIETY FOR DERMATOLOGICAL SURGERY
DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 30 JUNE 2024
| INCOME AND ENDOWMENTS Investment income Deposit account interest Charitable activities Courses & delegate income Membership income Exhibition income Sponsorship income Advertising income Total incoming resources EXPENDITURE Charitable activities Staff wages Social security Pensions Computer operating leases Insurance Advertising Accountancy Education and scholarship Computer cost Delegate course General administrative cost Professional cost Travel & accommodation Sundry Venue hire Storage fee Telephone cost Printing and stationery Medical supply & equipments Bank charges Distribution ASW profitshare Independent examination fee Depreciation of tangible fixed assets Total resources expended Net expenditure |
2024 as £ 4,028 165,674 27,365 15,601 23,301 150 232,091 236,119 77,001 2,874 1,936 999 459 65 6,406 3,320 7,444 9,261 1,163 17,224 17,828 48 80,978 1,238 283 1,665 14,147 3,849 - 2,400 334 250,922 250,922 (14,803) |
2023 restated £ 5,618 221,918 40,194 2,465 21,785 200 286,562 292,180 74,437 - - - 440 77 2,011 5,874 13,483 13,402 - 44,300 26,022 233 87,876 2,085 288 4,323 11,864 212 13,554 2,408 334 303,223 303,223 (11,043) |
|---|---|---|
This page does not form part of the statutory financial statements
Page 13